Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Vineland › NPI 1164487542
Hospital

Inspira Medical Centers, INC.

Inspira Medical Centers, INC. was paid $227.07M by Medicaid between Jan 2018 and Dec 2024, across 502 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoINSPIRA MEDICAL CENTERS, INC.
VINELAND, NJ 08360
33aNPI1164487542assigned 04/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$227.07M
24GClaims3,252,356
24DCodes billed502
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#5 of 93
Median peer was paid$30.60M
This provider vs. median7.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018438,153$29.63M
2019450,241$30.84M
2020395,314$29.13M
2021479,700$33.89M
2022529,829$39.32M
2023543,544$36.29M
2024incomplete415,575$27.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 88,894 78,758 $51.59M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 104,322 96,326 $39.92M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 47,924 42,921 $33.32M
G0378 Hospital observation service, per hour 5.7% 16,024 13,096 $13.01M
H0035 Mental health partial hospitalization, treatment, less than 24 hours 5.6% 39,168 3,497 $12.71M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.3% 30,885 29,404 $7.44M
A0427 Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 2.2% 18,132 15,555 $5.08M
59025 Fetal non-stress test 1.7% 10,622 4,035 $3.82M
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 1.5% 22,326 17,350 $3.44M
90837 Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient 1.2% 28,805 12,923 $2.81M
A0434 Specialty care transport (sct) 1.1% 5,537 4,933 $2.59M
A0425 Ground mileage, per statute mile <1% 53,778 42,663 $1.99M
490 more codes
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 4,587 $1.92M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 992 $1.58M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 60,066 $1.35M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 22,457 $1.24M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,965 $1.18M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 2,755 $1.14M
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 699 $1.10M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 459 $1.08M
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 34,342 $1.00M
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 15,720 $974K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,454 $841K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 43,091 $815K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,200 $811K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 25,880 $792K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 7,136 $779K
78815 Positron emission tomography (PET) for limited area imaging <1% 536 $775K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 9,318 $770K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 67,972 $764K
76830 Ultrasound, transvaginal <1% 5,981 $746K
95806 <1% 514 $733K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 5,203 $676K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 24,093 $675K
71046 Radiologic examination, chest; 2 views <1% 39,534 $590K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,145 $581K
OP710 <1% 13,135 $574K
76801 <1% 6,914 $476K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 543 $472K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 6,495 $437K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 14,451 $434K
93970 <1% 2,280 $428K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 169 $418K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 18,376 $412K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 8,305 $409K
90791 Psychiatric diagnostic evaluation <1% 3,466 $393K
96375 Therapeutic injection; each additional sequential IV push <1% 30,341 $393K
93971 <1% 3,555 $363K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 5,556 $358K
90834 Psychotherapy session, about 45 minutes <1% 4,832 $356K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 21,784 $355K
OP279 <1% 26,795 $352K
41899 Unlisted procedure, dentoalveolar structures <1% 199 $350K
70450 Computed tomography, head or brain; without contrast material <1% 18,194 $346K
77063 Screening digital breast tomosynthesis, bilateral <1% 6,062 $340K
47562 <1% 155 $327K
36415 Collection of venous blood by venipuncture <1% 134,109 $327K
A0433 Advanced life support, level 2 (als 2) <1% 882 $319K
96361 Intravenous infusion, hydration; each additional hour <1% 26,922 $312K
76770 <1% 3,033 $294K
77066 Tomosynthesis, mammo <1% 1,551 $292K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 11,100 $291K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 21,297 $288K
80048 Basic metabolic panel (calcium, ionized) <1% 76,350 $287K
71250 <1% 2,665 $284K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,821 $283K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 9,873 $281K
95811 <1% 181 $277K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 109,395 $270K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,076 $264K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,580 $255K
87631 <1% 8,519 $253K
94760 <1% 137,762 $253K
94060 <1% 962 $243K
76819 Fetal biophysical profile; without non-stress testing <1% 2,622 $241K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,186 $240K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,003 $229K
97161 <1% 6,054 $222K
76536 <1% 2,443 $222K
80053 Comprehensive metabolic panel <1% 41,494 $221K
76642 <1% 2,546 $220K
93880 <1% 1,027 $213K
71045 Radiologic examination, chest; single view <1% 24,995 $205K
99214 Doctor's office visit, returning patient (more involved) <1% 3,537 $204K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 5,021 $198K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 12,046 $186K
97802 <1% 1,647 $185K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 14,020 $185K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 14,024 $183K
73564 <1% 7,704 $183K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 7,576 $181K
OP272 <1% 9,549 $175K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,626 $168K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 8,902 $165K
77065 Tomosynthesis, mammo <1% 1,399 $165K
93975 <1% 3,690 $160K
73630 <1% 9,564 $159K
73221 <1% 246 $156K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 13,727 $155K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 228 $153K
93041 <1% 24,424 $153K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,622 $150K
93925 <1% 431 $150K
36000 <1% 22,972 $142K
97162 <1% 4,339 $139K
10060 <1% 1,882 $133K
76820 <1% 1,973 $133K
82962 <1% 36,411 $125K
OP259 <1% 126,666 $124K
86901 <1% 12,499 $122K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 7,599 $121K
97010 <1% 27,957 $120K
99213 Doctor's office visit, returning patient (routine) <1% 2,220 $117K
72110 <1% 3,612 $116K
73130 <1% 7,529 $111K
80076 <1% 42,423 $111K
90832 Psychotherapy session, about 30 minutes <1% 2,167 $106K
76818 <1% 852 $102K
G2251 Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion <1% 1,740 $100K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,103 $100K
72125 Computed tomography, cervical spine; without contrast material <1% 6,301 $100K
73030 <1% 6,038 $97K
84484 <1% 22,063 $96K
93017 <1% 294 $91K
90853 Group psychotherapy (other than of a multiple-family group) <1% 1,774 $90K
J3490 Unclassified drugs <1% 37,727 $90K
73610 <1% 7,418 $88K
84443 Thyroid stimulating hormone (TSH) <1% 7,620 $86K
70486 <1% 2,630 $84K
81003 <1% 71,304 $84K
97116 <1% 6,954 $82K
83880 <1% 11,623 $82K
72141 <1% 199 $82K
87086 Culture, bacterial; quantitative colony count, urine <1% 30,607 $82K
73110 <1% 5,012 $81K
83690 <1% 36,826 $80K
97803 <1% 1,059 $78K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,509 $78K
86850 <1% 10,468 $74K
83735 <1% 36,249 $65K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,405 $65K
70491 <1% 786 $65K
72197 <1% 63 $64K
86900 <1% 12,466 $62K
76870 <1% 1,261 $62K
85610 <1% 19,501 $59K
97535 Self-care/home management training, each 15 minutes <1% 7,811 $57K
0002A <1% 1,708 $55K
80061 Lipid panel <1% 4,885 $55K
81001 <1% 42,801 $54K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 31,183 $54K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,290 $54K
OP278 <1% 76 $54K
73502 <1% 2,995 $53K
86480 <1% 967 $52K
77080 <1% 646 $51K
0001A <1% 1,744 $50K
97165 <1% 2,379 $50K
12001 <1% 2,150 $50K
85027 <1% 9,667 $49K
72050 <1% 972 $45K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 140 $44K
92567 <1% 561 $44K
OP250 <1% 24,688 $43K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,144 $41K
94729 <1% 943 $41K
73590 <1% 3,386 $40K
87581 <1% 3,678 $40K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 212 $40K
74018 <1% 2,204 $40K
87486 <1% 3,678 $40K
12011 <1% 1,685 $40K
83605 <1% 7,846 $39K
J1644 Injection, heparin sodium, per 1000 units <1% 5,289 $39K
85730 <1% 14,975 $38K
97166 <1% 1,994 $38K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,292 $37K
80306 <1% 1,813 $37K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 6,757 $36K
92523 <1% 664 $35K
73080 <1% 2,876 $34K
J2704 Injection, propofol, 10 mg <1% 11,968 $34K
93458 <1% 12 $33K
77336 <1% 310 $33K
87186 <1% 6,875 $33K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 147 $33K
84702 <1% 6,675 $33K
72100 <1% 1,189 $32K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 14,124 $32K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,111 $31K
J7030 Infusion, normal saline solution , 1000 cc <1% 31,540 $31K
76821 <1% 260 $31K
87040 <1% 3,811 $30K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 5,947 $30K
74022 <1% 1,445 $30K
90714 <1% 4,973 $30K
73090 <1% 3,050 $29K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 16,668 $29K
12002 <1% 1,014 $29K
96376 <1% 4,214 $28K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 10,080 $28K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 11,500 $27K
72114 <1% 428 $27K
74183 <1% 38 $26K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 893 $26K
83036 Hemoglobin; glycosylated (A1C) <1% 4,785 $26K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 9,792 $25K
C1776 Joint device (implantable) <1% 22 $23K
80320 <1% 8,062 $23K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,233 $22K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,938 $22K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 26,991 $21K
82247 <1% 2,640 $21K
81025 <1% 24,845 $21K
84703 <1% 19,748 $21K
70496 <1% 502 $20K
94727 <1% 643 $20K
70498 <1% 642 $20K
87077 <1% 5,652 $19K
92588 <1% 121 $19K
88342 <1% 1,405 $19K
C1769 Guide wire <1% 1,336 $19K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 859 $19K
J2270 Injection, morphine sulfate, up to 10 mg <1% 12,919 $18K
82803 <1% 4,046 $18K
82248 <1% 3,809 $18K
51702 <1% 671 $18K
97163 <1% 650 $17K
73552 <1% 1,502 $17K
76881 <1% 118 $17K
OP270 <1% 451 $16K
J0690 Injection, cefazolin sodium, 500 mg <1% 4,287 $16K
76641 <1% 177 $16K
72070 <1% 529 $16K
73560 <1% 692 $15K
86803 <1% 844 $15K
36430 <1% 445 $15K
87081 <1% 7,629 $14K
94726 <1% 280 $14K
J2060 Injection, lorazepam, 2 mg <1% 5,087 $14K
73060 <1% 1,410 $14K
76000 <1% 945 $14K
97016 <1% 1,408 $14K
82550 <1% 3,580 $14K
92579 <1% 64 $13K
84100 <1% 4,616 $13K
J7050 Infusion, normal saline solution, 250 cc <1% 3,000 $13K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 15 $13K
95816 <1% 38 $12K
90675 <1% 35 $12K
0004A <1% 392 $12K
82330 <1% 3,295 $12K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,617 $12K
80329 <1% 1,837 $12K
Q3014 Telehealth originating site facility fee <1% 646 $12K
88304 <1% 1,784 $11K
85055 <1% 1,570 $11K
88307 <1% 453 $11K
71271 <1% 107 $11K
82375 <1% 4,136 $11K
A4311 Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) <1% 553 $11K
81329 <1% 97 $11K
97014 <1% 2,511 $11K
72220 <1% 324 $10K
86787 <1% 815 $10K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 161 $10K
84439 <1% 1,177 $10K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,693 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 198 $10K
29075 <1% 361 $10K
88300 <1% 554 $9K
82947 <1% 3,529 $9K
J1630 Injection, haloperidol, up to 5 mg <1% 2,714 $9K
80165 <1% 1,252 $9K
87147 <1% 7,737 $9K
95819 <1% 42 $9K
87210 <1% 11,647 $8K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 507 $8K
0071A <1% 223 $8K
87070 <1% 2,670 $8K
83050 <1% 4,136 $8K
72195 <1% 14 $8K
0072A <1% 205 $8K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,491 $8K
73140 <1% 945 $7K
73700 <1% 70 $7K
81401 <1% 97 $7K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,727 $7K
87340 <1% 1,234 $7K
82270 <1% 1,353 $7K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 5,310 $7K
76813 <1% 64 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 679 $6K
A0390 Als mileage (per mile) <1% 1,791 $6K
73562 <1% 228 $6K
J3370 Injection, vancomycin hcl, 500 mg <1% 1,177 $6K
85018 <1% 4,124 $6K
29405 <1% 174 $6K
73620 <1% 370 $6K
29540 <1% 382 $6K
80074 <1% 189 $6K
36600 <1% 684 $5K
84436 <1% 884 $5K
P9016 Red blood cells, leukocytes reduced, each unit <1% 383 $5K
82607 <1% 1,003 $5K
72040 <1% 194 $5K
86140 <1% 3,189 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 12,414 $5K
74174 <1% 88 $5K
85379 <1% 3,551 $5K
83540 <1% 1,444 $5K
29581 <1% 79 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $5K
84132 <1% 3,029 $5K
84295 <1% 2,951 $4K
73100 <1% 252 $4K
87205 <1% 675 $4K
82728 <1% 638 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 128 $4K
82435 <1% 2,951 $4K
OP229 <1% 84 $4K
73120 <1% 221 $4K
85652 <1% 3,033 $4K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,840 $4K
J1756 Injection, iron sucrose, 1 mg <1% 78 $4K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 67 $4K
94761 <1% 952 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 6,007 $4K
85384 <1% 1,401 $4K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 345 $4K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 28 $4K
84479 <1% 654 $4K
71101 <1% 189 $4K
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,794 $4K
0054A <1% 126 $4K
29130 <1% 442 $4K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 7,802 $4K
82010 <1% 2,023 $4K
86923 <1% 302 $3K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 558 $3K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 501 $3K
36416 <1% 898 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 328 $3K
70220 <1% 68 $3K
70360 <1% 218 $3K
0052A <1% 87 $3K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,828 $3K
86618 <1% 316 $3K
73600 <1% 190 $3K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 848 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 13,773 $3K
83615 <1% 1,200 $3K
88142 <1% 131 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 4,587 $3K
J3360 Injection, diazepam, up to 5 mg <1% 616 $3K
86762 <1% 821 $3K
96367 <1% 231 $3K
72082 <1% 26 $3K
19083 <1% 12 $2K
OP299 <1% 35 $2K
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 196 $2K
J8540 Dexamethasone, oral, 0.25 mg <1% 4,836 $2K
92587 <1% 16 $2K
97022 <1% 700 $2K
A4344 Indwelling catheter, foley type, two-way, all silicone or polyurethane, each <1% 180 $2K
J1940 Injection, furosemide, up to 20 mg <1% 1,158 $2K
84156 <1% 1,881 $2K
84550 <1% 1,490 $2K
86592 <1% 2,505 $2K
73070 <1% 179 $2K
82570 <1% 669 $2K
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals <1% 188 $2K
L2999 Lower extremity orthoses, not otherwise specified <1% 2,173 $2K
82746 <1% 496 $2K
82140 <1% 915 $2K
A4338 Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each <1% 244 $2K
J1790 Injection, droperidol, up to 5 mg <1% 1,110 $2K
83020 <1% 291 $2K
A4648 Tissue marker, implantable, any type, each <1% 75 $2K
73000 <1% 86 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,157 $2K
0003A <1% 60 $2K
76882 <1% 49 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 337 $2K
77062 <1% 845 $2K
82150 <1% 450 $2K
51701 <1% 86 $1K
87807 <1% 277 $1K
82533 <1% 40 $1K
0051A <1% 42 $1K
99152 <1% 167 $1K
72131 <1% 15 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 104 $1K
73503 <1% 158 $1K
J2760 Injection, phentolamine mesylate, up to 5 mg <1% 318 $1K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 74 $1K
72170 <1% 69 $1K
87071 <1% 893 $1K
80185 <1% 30 $1K
84145 <1% 221 $1K
J3480 Injection, potassium chloride, per 2 meq <1% 1,513 $1K
29515 <1% 85 $1K
82043 <1% 371 $1K
29530 <1% 199 $1K
96368 <1% 152 $1K
99153 Mod sedat endo service >5yrs <1% 105 $1K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 797 $1K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 95 $1K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 167 $1K
97018 <1% 663 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 37 $1K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 3,112 $1K
OP258 <1% 918 $988.48
J1956 Injection, levofloxacin, 250 mg <1% 27 $973.30
OP637 <1% 8,678 $944.48
80354 <1% 179 $874.75
90686 <1% 117 $866.58
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 901 $866.29
87899 <1% 175 $860.24
G0008 Administration of influenza virus vaccine <1% 81 $829.02
J2785 Injection, regadenoson, 0.1 mg <1% 12 $822.25
C9113 Injection, pantoprazole sodium, per vial <1% 712 $768.96
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 604 $746.98
74420 <1% 26 $731.95
29125 <1% 65 $702.52
85008 <1% 3,548 $682.70
J1815 Injection, insulin, per 5 units <1% 43 $676.80
90785 <1% 20 $675.15
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 391 $632.84
29126 <1% 45 $631.53
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 2,357 $626.77
J2550 Injection, promethazine hcl, up to 50 mg <1% 466 $616.26
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,586 $570.62
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 27 $517.52
86920 <1% 14 $512.57
90715 <1% 48 $512.47
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 61 $506.17
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 84 $479.32
78580 <1% 13 $478.58
C1729 Catheter, drainage <1% 188 $470.65
87073 <1% 372 $467.91
88341 <1% 30 $458.37
72072 <1% 14 $455.12
76937 <1% 15 $443.02
L1906 Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf <1% 219 $441.31
J1920 Injection, labetalol hydrochloride, 5 mg <1% 48 $436.59
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 947 $420.92
87185 <1% 117 $417.89
J1953 Injection, levetiracetam, 10 mg <1% 736 $412.14
86780 <1% 108 $395.65
86317 <1% 54 $387.74
86703 <1% 42 $360.90
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 356 $340.74
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 77 $308.53
77061 <1% 298 $293.64
86308 <1% 199 $282.40
74019 <1% 14 $256.50
82731 <1% 14 $236.40
83655 <1% 25 $202.17
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) <1% 21 $198.41
C1758 Catheter, ureteral <1% 42 $156.64
88112 <1% 17 $147.58
L8699 Prosthetic implant, not otherwise specified <1% 93 $141.71
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 123 $138.11
J0571 Buprenorphine, oral, 1 mg <1% 110 $125.62
J1836 Injection, metronidazole, 10 mg <1% 273 $118.05
91300 <1% 3,848 $110.00
83550 <1% 15 $101.80
73660 <1% 14 $81.03
84481 <1% 16 $79.59
J0360 Injection, hydralazine hcl, up to 20 mg <1% 77 $79.44
84112 <1% 13 $78.49
J0736 Injection, clindamycin phosphate, 300 mg <1% 83 $77.79
76377 <1% 13 $59.94
91307 <1% 426 $58.00
A4605 Tracheal suction catheter, closed system, each <1% 51 $57.25
A9270 Non-covered item or service <1% 3,774 $55.58
82009 <1% 36 $54.56
A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries <1% 14 $42.05
85660 <1% 12 $42.00
82553 <1% 15 $41.25
J7510 Prednisolone oral, per 5 mg <1% 140 $27.67
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 280 $23.85
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 98 $22.88
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 103 $22.04
87150 <1% 14 $18.43
85370 <1% 13 $15.34
J1171 Injection, hydromorphone, 0.1 mg <1% 74 $13.91
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 16 $13.04
J7060 5% dextrose/water (500 ml = 1 unit) <1% 48 $12.72
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 37 $12.53
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 18 $10.20
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc <1% 13 $8.25
85007 <1% 724 $6.94
J2470 Injection, pantoprazole sodium, 40 mg <1% 61 $6.30
91305 <1% 271 $4.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 73 $2.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 13 $0.00
88302 0% 13 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 12 $0.00
OP450 0% 29 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialO'CONNELL, JAMES (DIRECTOR REVENUE CYCLE)
Same official

Other billing entities under O'CONNELL, JAMES

Full network →
ProviderLocationPaid
Inspira Medical Centers, INC.Mullica Hill, NJ$56.65M
Inspira Medical Centers, INC.Elmer, NJ$30.55M
Inspira Medical Centers, INC.Woodbury, NJ$27.14M
Inspira Health Network Medical Group, P.C.Glassboro, NJ$5.22M
Inspira Medical Centers, INC.Bridgeton, NJ$73K
Inspira Medical Centers, INC.Woodbury, NJ$33K
Inspira Medical Centers, INC.Woodbury, NJ$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.